TYMS and hepatocellular carcinoma: In patients with colorectal cancer, TS polymorphisms predict response to 5-FU-based chemotherapy and influence survival.[10] Whether TS polymorphisms are associated with overall survival in patients after resection of HCC who did not receive adjuvant therapy is not known.